Back
FB Financial Vs. Alnylam Pharmaceuticals Industry Stock Comparison
Buy
64
FBK
FB Financial
Last Price:
$47.03
Seasonality Move:
4.52%
Sell
43
ALNY
Alnylam Pharmaceuticals
Last Price:
$268.29
Seasonality Move:
7.6%
Buy
64
FB Financial (FBK)
is a Buy
Is FB Financial a Buy, Sell or Hold?
-
The current FB Financial [FBK] share price is $47.94. The Score for FBK is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
-
FBK is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
43
Alnylam Pharmaceuticals (ALNY)
is a Sell
Is Alnylam Pharmaceuticals a Buy, Sell or Hold?
-
The current Alnylam Pharmaceuticals [ALNY] share price is $271.02. The Score for ALNY is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
-
ALNY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
FBK Stock Price Chart
What is FB Financial's stock price today?
-
The FB Financial share price today is $47.94Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FBK is experiencing slight buying pressure.
ALNY Stock Price Chart
What is Alnylam Pharmaceuticals's stock price today?
-
The Alnylam Pharmaceuticals share price today is $271.02The current trend is moderately bullish and ALNY is experiencing slight buying pressure.
FBK Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.73 | Sell |
Relative Strength Index (14 RSI): | 47.92 | Sell |
Chaikin Money Flow: | 8028 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (46.38 - 49.8) | Sell |
Bollinger Bands (100): | (48.82 - 55.26) | Sell |
ALNY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 5.53 | Buy |
Relative Strength Index (14 RSI): | 57.28 | Buy |
Chaikin Money Flow: | 106003 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (238.42 - 267) | Buy |
Bollinger Bands (100): | (240.58 - 270.64) | Buy |
FBK Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 47.6 | Buy |
20-day SMA: | 47.56 | Buy |
50-day SMA: | 50.33 | Sell |
200-day SMA: | 47.99 | Sell |
8-day EMA: | 47.68 | Buy |
20-day EMA: | 48.03 | Sell |
50-day EMA: | 49.54 | Sell |
200-day EMA: | 47.75 | Buy |
ALNY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 268.31 | Buy |
20-day SMA: | 253.84 | Buy |
50-day SMA: | 259.68 | Buy |
200-day SMA: | 253.36 | Buy |
8-day EMA: | 268.69 | Buy |
20-day EMA: | 260.57 | Buy |
50-day EMA: | 257.45 | Buy |
200-day EMA: | 244.33 | Buy |
FB Financial Earnings Growth & FBK Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.14 per share, an increase next quarter of $0.01 per share, an increase this year of $0.23 per share, and an increase next year of $0.44 per share.
Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.91 per share, an increase next quarter of $0.05 per share, an increase this year of $1.08 per share, and an increase next year of $2.75 per share.
FB Financial Technical Analysis
Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
14 | 17 | 18 | 19 | 20 | 21 | 24 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Alnylam Pharmaceuticals Technical Analysis
Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
14 | 17 | 18 | 19 | 20 | 21 | 24 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |